{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:47:44Z","timestamp":1774284464130,"version":"3.50.1"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.2169\/internalmedicine.1178-22","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T22:12:42Z","timestamp":1675203162000},"page":"2715-2724","source":"Crossref","is-referenced-by-count":8,"title":["Severe TAFRO Syndrome Mimicking Hepatorenal Syndrome Successfully Treated with a Multidisciplinary Approach: A Case Report and Literature Review"],"prefix":"10.2169","volume":"62","author":[{"given":"Shinya","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Tanigaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Kyoto University, Japan"},{"name":"Department of Nephrology, Kansai Denryoku Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Muro","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minami","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Japan"},{"name":"Department of Radiology, Tenri Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Akizuki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Minamiguchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Fukuma","sequence":"additional","affiliation":[{"name":"Human and Health Sciences, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, Kyoto University, Japan"},{"name":"Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Takai K, Nikkuni K, Shibuya H, Hashidate H. [Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly]. Rinsho Ketsueki Jpn (J Clin Hematol) 51: 320-325, 2010."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Masaki Y, Kawabata H, Fujimoto S, et al. Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. J Clin Exp Hematop 59: 175-178, 2019.","DOI":"10.3960\/jslrt.19021"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fujimoto S, Sakai T, Kawabata H, et al. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Am J Hematol 94: 975-983, 2019.","DOI":"10.1002\/ajh.25554"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fujimoto S, Kawabata H, Sakai T, et al. Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan. Int J Hematol 113: 73-80, 2021.","DOI":"10.1007\/s12185-020-03008-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Masaki Y, Kawabata H, Takai K, et al. 2019 updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol 111: 155-158, 2020.","DOI":"10.1007\/s12185-019-02780-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ozeki T, Tsuji M, Yamamoto J, Shigematsu C, Maruyama S. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome. CEN Case Rep 7: 243-247, 2018.","DOI":"10.1007\/s13730-018-0338-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takayama Y, Kubota T, Ogino Y, Ohnishi H, Togitani K, Yokoyama A. TAFRO syndrome with disseminated intravascular coagulation successfully treated with tocilizumab and recombinant thrombomodulin. Intern Med (Tokyo, Japan) 57: 1291-1296, 2018.","DOI":"10.2169\/internalmedicine.9484-17"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shimada Y, Adachi M, Kobayashi N, et al. A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones. Clin Case Rep 6: 638-643, 2018.","DOI":"10.1002\/ccr3.1417"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito S, Uchida T, Itai H, et al. Serial manifestation of acute kidney injury and nephrotic syndrome in a patient with TAFRO syndrome. Intern Med 57: 3129-3133, 2018.","DOI":"10.2169\/internalmedicine.0806-18"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fujiwara Y, Ito K, Takamura A, Nagata K. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report. J Med Case Rep 12: 295, 2018.","DOI":"10.1186\/s13256-018-1814-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Xia P, Zhang L, Zou M, et al. Acute kidney injury caused by TAFRO syndrome in a Chinese patient: efficacy of long-term corticosteroids combined with bortezomib and cyclophosphamide. Kidney Blood Press Res 45: 623-630, 2020.","DOI":"10.1159\/000505458"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hashimoto K, Sano T, Honma Y, et al. An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions. CEN Case Rep 8: 48-54, 2019.","DOI":"10.1007\/s13730-018-0363-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nagayama Y, Yamano M, Yagame M, et al. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review. BMC Nephrol 20: 375, 2019.","DOI":"10.1186\/s12882-019-1574-9"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Shirai T, Onishi A, Waki D, Saegusa J, Morinobu A. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review. Medicine 97: e11045, 2018.","DOI":"10.1097\/MD.0000000000011045"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kikuchi T, Shimizu T, Toyama T, Abe R, Okamoto S. Successful treatment of TAFRO syndrome with tocilizumab, prednisone, and cyclophosphamide. Intern Med 56: 2205-2211, 2017.","DOI":"10.2169\/internalmedicine.8522-16"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Okumura M, Ujiro A, Otsuka Y, et al. Cardiac arrest caused by rapidly increasing ascites in a patient with TAFRO syndrome: a case report. Acute Med Surg 4: 344-348, 2017.","DOI":"10.1002\/ams2.278"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Suzuki K, Matsumoto T, Iwashita Y, et al. Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab. Int J Hematol 109: 737-743, 2019.","DOI":"10.1007\/s12185-019-02604-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fujiki T, Hirasawa S, Watanabe S, Iwamoto S, Ando R. Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome. CEN Case Rep 6: 105-110, 2017.","DOI":"10.1007\/s13730-017-0253-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Iwaki N, Gion Y, Kondo E, et al. Elevated serum interferon \u03b3-induced protein 10 kDa is associated with TAFRO syndrome. Sci Rep 7: 42316, 2017.","DOI":"10.1038\/srep42316"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Leurs A, Gnemmi V, Lionet A, et al. Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A case report and literature review. Front Immunol 10: 1489, 2019.","DOI":"10.3389\/fimmu.2019.01489"},{"key":"21","unstructured":"21. Matsuhisa T, Takahashi N, Nakaguro M, et al. Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature. Nagoya J Med Sci 81: 519-528, 2019."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yamaguchi Y, Maeda Y, Shibahara T, et al. Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review. Mod Rheumatol Case Rep 4: 302-309, 2020.","DOI":"10.1080\/24725625.2020.1717747"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Godeau B, Chevret S, Varet B, et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 359: 23-29, 2002.","DOI":"10.1016\/S0140-6736(02)07275-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. George JN, El-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 331: 1207-1211, 1994.","DOI":"10.1056\/NEJM199411033311807"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Cheng Y, Wong RS, Soo YO, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 349: 831-836, 2003.","DOI":"10.1056\/NEJMoa030254"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mizuno H, Sawa N, Watanabe S, et al. The clinical and histopathological feature of renal manifestation of TAFRO syndrome. Kidney Int Rep 5: 1172-1179, 2020.","DOI":"10.1016\/j.ekir.2020.05.004"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_1178-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:28:51Z","timestamp":1715574531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_1178-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":26,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1178-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"article-number":"1178-22"}}